Cargando…
Rapamycin Inhibits Glioma Cells Growth and Promotes Autophagy by miR-26a-5p/DAPK1 Axis
BACKGROUND: Glioma is a common intracranial malignant tumor with high rates of invasiveness and mortality. This study aimed to investigate the mechanism of rapamycin in glioma. METHODS: U118-MG cells were treated with and without rapamycin in vivo and then collected for RNA sequencing. Differentiall...
Autores principales: | Wang, Zheng, Wang, Xiaoxi, Cheng, Fei, Wen, Xue, Feng, Shi, Yu, Fang, Tang, Hui, Liu, Zhengjin, Teng, Xiaodong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997605/ https://www.ncbi.nlm.nih.gov/pubmed/33790644 http://dx.doi.org/10.2147/CMAR.S298468 |
Ejemplares similares
-
Glioma stem cells-derived exosomal miR-26a promotes angiogenesis of microvessel endothelial cells in glioma
por: Wang, Zhi-Fei, et al.
Publicado: (2019) -
AMPK activates DAPK2 to promote autophagy
por: Shiloh, Ruth, et al.
Publicado: (2018) -
miR-124 Alleviates Ischemic Stroke-Induced Neuronal Death by Targeting DAPK1 in Mice
por: Shi, Yan, et al.
Publicado: (2021) -
Inhibition of miR‐34a‐5p can rescue disruption of the p53‐DAPK axis to suppress progression of clear cell renal cell carcinoma
por: Jing, Zhi‐Fei, et al.
Publicado: (2019) -
lncRNA MALAT1/miR-26a/26b/ST8SIA4 axis mediates cell invasion and migration in breast cancer cell lines
por: Wang, Nan, et al.
Publicado: (2021)